Aroa Biosurgery Limited (ARX.AX)
AUD 0.7
(2.96%)
AUD 0.7
(2.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 101.82 Million AUD | -6.6% |
| 2023 | 109.07 Million AUD | 4.17% |
| 2022 | 104.7 Million AUD | 43.19% |
| 2021 | 73.12 Million AUD | -11.4% |
| 2020 | 82.53 Million AUD | 117.42% |
| 2019 | 37.96 Million AUD | 165.41% |
| 2018 | 14.3 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 102.98 Million AUD | -1.73% |
| 2024 Q4 | 101.82 Million AUD | -1.08% |
| 2024 FY | 101.82 Million AUD | -6.65% |
| 2024 Q1 | 103.74 Million AUD | -4.89% |
| 2024 Q2 | 104.8 Million AUD | 1.02% |
| 2023 Q3 | 108.68 Million AUD | 7.05% |
| 2023 FY | 109.07 Million AUD | 4.17% |
| 2023 Q4 | 109.07 Million AUD | 0.36% |
| 2023 Q2 | 101.52 Million AUD | 0.0% |
| 2022 FY | 104.7 Million AUD | 43.19% |
| 2022 Q2 | 108.4 Million AUD | 0.0% |
| 2022 Q4 | 104.7 Million AUD | 0.0% |
| 2021 Q4 | 73.12 Million AUD | 0.0% |
| 2021 FY | 73.12 Million AUD | -11.4% |
| 2021 Q2 | 76.03 Million AUD | 0.0% |
| 2020 FY | 82.53 Million AUD | 117.42% |
| 2020 Q4 | 44.52 Million AUD | 0.0% |
| 2019 FY | 37.96 Million AUD | 165.41% |
| 2018 FY | 14.3 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 15.159% |
| Adherium Limited | 9.88 Million AUD | -929.842% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -794.824% |
| Anteris Technologies Ltd | 45.7 Million AUD | -122.799% |
| Control Bionics Limited | 9.02 Million AUD | -1027.934% |
| CardieX Limited | 12.64 Million AUD | -704.931% |
| Compumedics Limited | 40.35 Million AUD | -152.297% |
| Cochlear Limited | 2.74 Billion AUD | 96.291% |
| CleanSpace Holdings Limited | 26.05 Million AUD | -290.846% |
| Cyclopharm Limited | 45.91 Million AUD | -121.766% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | -324.765% |
| Nova Eye Medical Limited | 29.88 Million AUD | -240.747% |
| HeraMED Limited | 2.95 Million AUD | -3349.15% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -736.25% |
| ImpediMed Limited | 46.98 Million AUD | -116.707% |
| InhaleRx Limited | 1.57 Million AUD | -6357.172% |
| LBT Innovations Limited | 7.93 Million AUD | -1183.85% |
| Micro-X Limited | 26.89 Million AUD | -278.591% |
| Neurotech International Limited | 12.21 Million AUD | -733.693% |
| OncoSil Medical Limited | 6.71 Million AUD | -1415.57% |
| PolyNovo Limited | 109.16 Million AUD | 6.728% |
| Respiri Limited | 6.19 Million AUD | -1544.702% |
| SomnoMed Limited | 69.8 Million AUD | -45.867% |
| Universal Biosensors, Inc. | 30.12 Million AUD | -238.051% |
| Uscom Limited | 5.13 Million AUD | -1883.049% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -808.688% |